Skip to content

Implantation of Porous Titanium Prosthesis in Laryngeal Surgery

Implantation of Porous Titanium Prosthesis in Laryngeal Surgery

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00213863
Enrollment
10
Registered
2005-09-21
Start date
2010-12-31
Completion date
2016-11-30
Last updated
2012-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vocal Cord Paralysis

Keywords

porous titanium implants, thyroplasty, vocal cord paralysis, male or female more than 18 years old

Brief summary

This study evaluates a medialization implant to treat vocal cord paralysis, to permit it to adjust the quality of the voice under local or general anesthesia. The aim is to restore phonation using a porous titanium prosthesis in laryngeal surgery.

Interventions

DEVICEVocal fold medialization (thyroplasty) prosthesis by insertion of a new implant allowing very easy and quick setting

The porous titanium prosthesis is implanted under local anaesthesia. Neck incision is performed in order to expose the thyroidal cartilage. A window is then opened in this cartilage, and the implant is placed in contact with the vocal muscles. The patient is then asked to speak in order to achieve the implant best setting.

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males or females greater than 18 years old

Exclusion criteria

* Age less than 18 years * Pregnant women * Local carcinoma excluding radiotherapeutic or surgical control * Bad general condition * Contraindication to general anesthesia * Non-controlled diabetes

Design outcomes

Primary

MeasureTime frame
Nasofibroscopy8 days and 3 months after surgery
Voice control and recording8, 15, 30 days, 3, 6 months after surgery and then, every 6 months during the whole trial
All types of complication8, 15, 30 days, 3, 6 months after surgery and then, every 6 months during the whole trial

Countries

France

Contacts

Primary ContactChristian Debry, MD
christian.debry@chru-strasbourg.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026